Found: 112
Select item for more details and to access through your institution.
Adding ultrasound to treat-to-target shows no benefit in achieving clinical remission nor in slowing radiographic progression in rheumatoid arthritis: results from a multicenter prospective cohort.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 6, p. 1833, doi. 10.1007/s10067-024-06978-5
- By:
- Publication type:
- Article
Prevalence of anti-neutrophil cytoplasmic antibody-associated vasculitis in the south of France, using the capture-recapture method.
- Published in:
- Rheumatology, 2024, v. 63, n. 6, p. 1552, doi. 10.1093/rheumatology/kead557
- By:
- Publication type:
- Article
Repurposing the Fibrosis-4 Score in Rheumatoid Arthritis: Data from the ESPOIR Cohort.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 7, p. 1905, doi. 10.3390/jcm13071905
- By:
- Publication type:
- Article
Prevention of Radiographic Progression in Higher-Risk Patients with Rheumatoid Arthritis Using Filgotinib in Phase III Studies: Narrative Review of Post Hoc Analyses.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 6, p. 1399, doi. 10.1007/s40744-023-00590-w
- By:
- Publication type:
- Article
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM.
- Published in:
- Rheumatology, 2023, v. 62, n. 9, p. 2989, doi. 10.1093/rheumatology/kead021
- By:
- Publication type:
- Article
Identification of Symptom Phenotypes of Hand Osteoarthritis Using Hierarchical Clustering: Results From the DIGICOD Cohort.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 7, p. 1494, doi. 10.1002/acr.25047
- By:
- Publication type:
- Article
Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results.
- Published in:
- Modern Rheumatology, 2023, v. 33, n. 4, p. 668, doi. 10.1093/mr/roac084
- By:
- Publication type:
- Article
Influence of Social Support, Financial Status, and Lifestyle on the Disparity Between Inflammation and Disability in Rheumatoid Arthritis.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 5, p. 1026, doi. 10.1002/acr.24996
- By:
- Publication type:
- Article
Risk of Cancer After Initiation of Targeted Therapies in Patients With Rheumatoid Arthritis and a Prior Cancer: Systematic Review With Meta‐Analysis.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 2, p. 260, doi. 10.1002/acr.24784
- By:
- Publication type:
- Article
Geographic Analysis of the Safety and Efficacy of Filgotinib in Rheumatoid Arthritis.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 1, p. 35, doi. 10.1007/s40744-022-00494-1
- By:
- Publication type:
- Article
Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 1, p. 53, doi. 10.1007/s40744-022-00498-x
- By:
- Publication type:
- Article
Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Exploring the disparity between inflammation and disability in the 10-year outcomes of people with rheumatoid arthritis.
- Published in:
- Rheumatology, 2022, v. 61, n. 12, p. 4687, doi. 10.1093/rheumatology/keac137
- By:
- Publication type:
- Article
A Risk Score to Detect Subclinical Rheumatoid Arthritis–Associated Interstitial Lung Disease.
- Published in:
- Arthritis & Rheumatology, 2022, v. 74, n. 11, p. 1755, doi. 10.1002/art.42162
- By:
- Publication type:
- Article
Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 10, p. 3035, doi. 10.1007/s10067-022-06218-8
- By:
- Publication type:
- Article
Correction to: Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
CXCR5/CXCL13 pathway, a key driver for migration of regulatory B10 cells, is defective in patients with rheumatoid arthritis.
- Published in:
- Rheumatology, 2022, v. 61, n. 5, p. 2185, doi. 10.1093/rheumatology/keab639
- By:
- Publication type:
- Article
Validation in the ESPOIR cohort of vitamin K-dependent protein S (PROS) as a potential biomarker capable of predicting response to the methotrexate/etanercept combination.
- Published in:
- Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-022-02762-5
- By:
- Publication type:
- Article
Glutamine promotes the generation of B10<sup>+</sup> cells via the mTOR/GSK3 pathway.
- Published in:
- European Journal of Immunology, 2022, v. 52, n. 3, p. 418, doi. 10.1002/eji.202149387
- By:
- Publication type:
- Article
Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1).
- Published in:
- Modern Rheumatology, 2022, v. 32, n. 2, p. 263, doi. 10.1093/mr/roab030
- By:
- Publication type:
- Article
Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abatacept.
- Published in:
- Rheumatology, 2022, v. 61, n. 3, p. 953, doi. 10.1093/rheumatology/keab438
- By:
- Publication type:
- Article
The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies.
- Published in:
- Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-021-02677-7
- By:
- Publication type:
- Article
Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One‐Year Results of a Double‐Blind, Placebo‐Controlled Study and Open‐Label Extension
- Published in:
- Arthritis & Rheumatology, 2022, v. 74, n. 1, p. 70, doi. 10.1002/art.41911
- By:
- Publication type:
- Article
Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 12, p. 4943, doi. 10.1007/s10067-021-05891-5
- By:
- Publication type:
- Article
Correction to: Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Current favourable 10-year outcome of patients with early rheumatoid arthritis: data from the ESPOIR cohort.
- Published in:
- Rheumatology, 2021, v. 60, n. 11, p. 5073, doi. 10.1093/rheumatology/keab398
- By:
- Publication type:
- Article
Ten-year analysis of the risk of severe outcomes related to low-dose glucocorticoids in early rheumatoid arthritis.
- Published in:
- Rheumatology, 2021, v. 60, n. 8, p. 3738, doi. 10.1093/rheumatology/keaa850
- By:
- Publication type:
- Article
Most Appropriate Conventional Disease-Modifying Antirheumatic Drug to Combine With Different Advanced Therapies in Rheumatoid Arthritis: A Systematic Literature Review With Meta-Analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Comparative efficacy of subcutaneous (CT-P13) and intravenous infliximab in adult patients with rheumatoid arthritis: a network meta-regression of individual patient data from two randomised trials.
- Published in:
- Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02487-x
- By:
- Publication type:
- Article
Impact of disease activity and treatments on ovarian reserve in patients with rheumatoid arthritis in the ESPOIR cohort.
- Published in:
- Rheumatology, 2021, v. 60, n. 4, p. 1863, doi. 10.1093/rheumatology/keaa535
- By:
- Publication type:
- Article
Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2).
- Published in:
- Rheumatology & Therapy, 2021, v. 8, n. 1, p. 199, doi. 10.1007/s40744-020-00261-0
- By:
- Publication type:
- Article
IL-10-producing regulatory B cells are present and functional in primary Sjögren patients.
- Published in:
- Immunologic Research, 2021, v. 69, n. 1, p. 107, doi. 10.1007/s12026-021-09171-x
- By:
- Publication type:
- Article
Correction to: IL-10-producing regulatory B cells are present and functional in primary Sjögren patients.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Evaluation of the impact of a nurse-led program of patient self-assessment and self-management in axial spondyloarthritis: results of a prospective, multicentre, randomized, controlled trial (COMEDSPA).
- Published in:
- Rheumatology, 2021, v. 60, n. 2, p. 888, doi. 10.1093/rheumatology/keaa480
- By:
- Publication type:
- Article
Ixekizumab, with or without concomitant methotrexate, improves signs and symptoms of PsA: week 52 results from Spirit-P1 and Spirit-P2 studies.
- Published in:
- Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-020-02388-5
- By:
- Publication type:
- Article
Cytomegalovirus infection: friend or foe in rheumatoid arthritis?
- Published in:
- Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-020-02398-3
- By:
- Publication type:
- Article
Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks.
- Published in:
- Rheumatology & Therapy, 2020, v. 7, n. 4, p. 759, doi. 10.1007/s40744-020-00225-4
- By:
- Publication type:
- Article
Association Between Vitamin D Deficiency and Disease Activity, Disability, and Radiographic Progression in Early Rheumatoid Arthritis: The ESPOIR Cohort.
- Published in:
- 2020
- By:
- Publication type:
- journal article
An updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients: pooled analyses from several databases.
- Published in:
- Rheumatology, 2020, v. 59, n. 8, p. 1842, doi. 10.1093/rheumatology/kez542
- By:
- Publication type:
- Article
Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RA.
- Published in:
- Journal of Rheumatology, 2020, v. 47, n. 6, p. 796, doi. 10.3899/jrheum.190302
- By:
- Publication type:
- Article
Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort.
- Published in:
- Journal of Rheumatology, 2020, v. 47, n. 6, p. 809, doi. 10.3899/jrheum.190303
- By:
- Publication type:
- Article
Occurrence of anterior uveitis in patients with spondyloarthritis treated with tumor necrosis factor inhibitors: comparing the soluble receptor to monoclonal antibodies in a large observational cohort.
- Published in:
- Arthritis Research & Therapy, 2020, v. 22, n. 1, p. 1, doi. 10.1186/s13075-020-02187-y
- By:
- Publication type:
- Article
Low Influenza, Pneumococcal and Diphtheria–Tetanus–Poliomyelitis Vaccine Coverage in Patients with Primary Sjögren's Syndrome: A Cross-Sectional Study.
- Published in:
- Vaccines, 2020, v. 8, n. 1, p. 3, doi. 10.3390/vaccines8010003
- By:
- Publication type:
- Article
Safety results of ixekizumab with 1822.2 patient-years of exposure: an integrated analysis of 3 clinical trials in adult patients with psoriatic arthritis.
- Published in:
- Arthritis Research & Therapy, 2020, v. 22, n. 1, p. 1, doi. 10.1186/s13075-020-2099-0
- By:
- Publication type:
- Article
Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cardiovascular Morbidity and Mortality in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. 1, doi. 10.1186/s13075-019-2020-x
- By:
- Publication type:
- Article
Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-1909-8
- By:
- Publication type:
- Article
Shifting from a Rheumatologic Point of View toward Patient-centered Care in Rheumatoid Arthritis with an Integrated Management of Comorbidities.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice